Approaching the RSV season with a nursing plan of action

Area of Science:

• Pediatric infectious diseases
• Virology
• Respiratory medicine

Background:

• Respiratory Syncytial Virus (RSV) is a common virus infecting nearly all children by age 4.
• Severe lower respiratory infections from RSV lead to approximately 90,000 hospitalizations in US infants and young children annually between November and March.
• While most infections are mild, some children experience considerable morbidity.

Framework:

• The symposium focused on identifying at-risk infants and children requiring hospitalization for RSV.
• It explored the role of nurses in managing hospitalized patients with RSV.
• Considerations for environmental exposure risks of ribavirin aerosol to healthcare personnel were discussed.
• Specialized care for mechanically ventilated patients with RSV was also addressed.

Implementation:

• Symptomatic treatment is a cornerstone of care for severe RSV infections.
• Antiviral therapy using ribavirin aerosol is approved for treating severe RSV cases.
• Healthcare personnel face minimal occupational risk from ribavirin aerosol administration.

Implications:

• Effective management strategies, including symptomatic and antiviral treatments, can significantly reduce severe morbidity in vulnerable pediatric populations.
• Understanding risk factors and implementing appropriate nursing care are crucial for optimizing outcomes in hospitalized children with RSV.
• Further research and clinical guidelines are essential for managing RSV outbreaks and improving patient care.